BSE filing, BSE: 544687. Summary written from the filing by ALFA Finder's alert engine.
Hannah Joseph Hospital Ltd: key numbers
- Share price
- ₹113.00
- Market cap
- ₹256.5 Cr
- Revenue (annual)
- ₹92.05 Cr
- Net profit (annual)
- ₹11.18 Cr
- P/E (TTM)
- 22.9×Sector 52.0×
- Promoter holding
- 71.50%
- FII holding
- 0.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hannah Joseph Hospital Ltd
All →Hannah Joseph Hospital Board Meeting Date
Hannah Joseph Hospital Ltd intimated a Board meeting on 05/11/2026 to approve H1 FY27 unaudited results. The trading window has been closed pending that announcement.
Hannah Joseph Hospital Business Update
Hannah Joseph Hospital received the 'Honours for Healthcare Excellence in Neurosciences' at CII TN MedClave 2026. The award recognises its multidisciplinary Neurosciences services in Tamil Nadu.
Hannah Joseph Hospital Other Announcement
The company filed its quarterly shareholding pattern as mandated by SEBI regulations. This routine disclosure presents the distribution of equity among promoters and public shareholders.
Hannah Joseph Hospital Promoter Buying
Promoter Daniel Dayanand Fenn acquired 2,000 equity shares of Hannah Joseph Hospital Limited through an open market purchase. This transaction increases the total promoter group stake to 71.502%.
- Promoter stake change
- +0.01%
Hannah Joseph Hospital Promoter Buying
Promoter Daniel Dayanand Fenn bought 2,000 open-market Hannah Joseph Hospital shares, raising his stake to 0.053%. A small SAST 29(2) disclosure with no stated transaction price.
- Promoter stake change
- +0.01%
Hannah Joseph Hospital Business Update
Hannah Joseph Hospital Limited received the "Winner" award for "Best Healthcare Digital Initiative" at the 5th CII WR Health Innovation Awards 2026.
- From
- Confederation of Indian Industry (CII)
Other board meeting date announcements
All →INDO SMC Board Meeting Date
INDO SMC Ltd has scheduled a board meeting for 3 November 2026 to consider unaudited financial results for the half-year ended 30 September 2026. The filing also notes the trading window closure, which is not itself a material event.
BNR Udyog Board Meeting Date
BNR Udyog Ltd has scheduled a board meeting for 11 November 2026 to consider unaudited quarterly and half-year results ended 30 September 2026 and the limited review report. This is a prior intimation, so no decisions have been taken yet.
Jindal Worldwide Board Meeting Date
Jindal Worldwide Ltd announces prior intimation of a board meeting on 05 November 2026 to consider unaudited standalone and consolidated results for quarter and half year ended 30 September 2026. The filing is a notice only, with no decisions taken yet.
IKIO Technologies Board Meeting Date
IKIO Technologies has scheduled a board meeting on 5 November 2026 to consider unaudited standalone and consolidated quarterly results for September 2026. This is an advance notice; the results are not yet approved.
Kiri Industries Board Meeting Date
Kiri Industries has scheduled a board meeting on 5 November 2026 to consider its unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. This is a future meeting notice, so the results are not yet approved.
Apollo Pipes Board Meeting Date
Apollo Pipes scheduled a board meeting for 5 November 2026 to consider Q2 and half-year results. The trading window reopens on 8 November 2026.